Literature DB >> 9891705

Ankylosing spondylitis. Clinical features.

S van der Linden1, D van der Heijde.   

Abstract

The clinical spectrum of ankylosing spondylitis (AS) is wider than just symptomatic sacroiliitis. The disease may be atypical or may occur as forme fruste. Atypical cases are encompassed in classification criteria for the whole family of spondyloarthropathies. AS may result primarily from additive genetic variability. Nonsteroidal anti-inflammatory drugs and physical exercise remain the cornerstone in the treatment of AS. Core sets for the assessment of the disease now exist for different treatment settings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891705     DOI: 10.1016/s0889-857x(05)70036-3

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  32 in total

Review 1.  Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.

Authors:  J Sieper; M Rudwaleit
Journal:  Ann Rheum Dis       Date:  2004-11-04       Impact factor: 19.103

2.  Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis.

Authors:  You-Fan Peng; Qiong Zhang; Ling Cao; Yang Liu; Dan Chen; Yu-Kun Sun; Zhao-Xia Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Stress proteins in the pathogenesis of spondyloarthritis.

Authors:  José Pablo Romero-López; María Lilia Domínguez-López; Rubén Burgos-Vargas; Ethel García-Latorre
Journal:  Rheumatol Int       Date:  2018-05-31       Impact factor: 2.631

4.  Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis.

Authors:  Abdellah El Maghraoui; Saida Tellal; Souad Chaouir; Khalil Lebbar; Ahmed Bezza; Abderrazak Nouijai; Lahsen Achemlal; Sanaa Bouhssain; El Mostapha Derouiche
Journal:  Clin Rheumatol       Date:  2004-12-08       Impact factor: 2.980

5.  IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents.

Authors:  Valderilio Feijó Azevedo; J R Faria-Neto; Andrea Stinghen; Pedro G Lorencetti; Wagner P Miller; Beatriz P Gonçalves; Carla C Szyhta; Roberto Pecoits-Filho
Journal:  Rheumatol Int       Date:  2013-01-08       Impact factor: 2.631

6.  Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.

Authors:  Fausto Salaffi; Rossella De Angelis; Marina Carotti; Marwin Gutierrez; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

7.  Variables related to utility in patients with ankylosing spondylitis.

Authors:  Rafael Ariza-Ariza; Blanca Hernández-Cruz; Gloria López-Antequera; Federico Navarro-Sarabia
Journal:  Clin Rheumatol       Date:  2008-09-30       Impact factor: 2.980

8.  Taylor's approach in an ankylosing spondylitis patient posted for percutaneous nephrolithotomy: A challenge for anesthesiologists.

Authors:  Parul Jindal; Gaurav Chopra; Amit Chaudhary; Aslam Aziz Rizvi; J P Sharma
Journal:  Saudi J Anaesth       Date:  2009-07

Review 9.  Efficacy of tripterygium glycosides tablet in treating ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hong Li; Feng Guo; Yu-chun Luo; Jian-ping Zhu; Jian-liang Wang
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

10.  The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay.

Authors:  C Sullivan; K Quinn; S Harney; J G Ryan
Journal:  Ir J Med Sci       Date:  2013-12-21       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.